Soluble urokinase-type plasminogen activator receptor (suPAR) is associated with risk for thromboembolic complications and mortality in patients with COVID-19
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: COVID-19 and percutaneous intervention
Cardiac arrest in patients hospitalized for COVID-19: a tertiary medical center retrospective cohort study
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Arrhythmias e-posters
ESC 365 is supported by
